Essential Pro Study ( rEPIC04E-HK )
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFundación EPIC
About this trial
Single center, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Essential Pro to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with Essential Pro.
Eligibility criteria
Qualifiers
Patient treated with Essential Pro according to routine hospital practice and following instructions for use
Informed consent signed
Disqualifiers
Not meet inclusion criteria
Trial design
Treatments tested in this trial
- Essential pro
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov